Abstract Details
|
Madeline Cheshire
PRESENTER |
Ms. Cheshire has nothing to disclose. |
| Emma Dereskewicz | Ms. Dereskewicz has nothing to disclose. |
| Batuhan Ayci, MD (Istanbul University-Cerrahpasa) | Mr. Ayci has nothing to disclose. |
| Jonadab Dos Santos Silva, MD, PhD | Dr. Dos Santos Silva has nothing to disclose. |
| Qingying Feng | Miss Feng has nothing to disclose. |
| Julia Galasso | Ms. Galasso has nothing to disclose. |
| Francesco La Rosa, PhD | Dr. La Rosa has nothing to disclose. |
| James F. Sumowski (Icahn School of Medicine At Mount Sinai) | Mr. Sumowski has nothing to disclose. |
| Erin S. Beck, MD (Icahn School of Medicine at Mount Sinai) | Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care. |